Skip to main content

Table 4 Latent class estimates (posterior mean and 95% credibility intervals (PCI)) of test Se and Sp and Divisional seroprevalence for the sub-data set (juveniles only) using all three tests and pairs of tests in combination

From: Evaluation of three 3ABC ELISAs for foot-and-mouth disease non-structural antibodies using latent class analysis

 

All three tests

I-ELISA+C-ELISA

I-ELISA+CHEKIT

CHEKIT+C-ELISA

Parameter

Mean

95% PCI

Mean

95% PCI

Mean

95% PCI

mean

95% PCI

SeCHEKIT

26.1

(20.1; 32.6)

-

-

43.2

(22.3; 82.0)

47.7

(22.5; 90.0)

SpCHEKIT

99.1

(97.9; 99.8)

-

-

99.2

(97.7;100.0)

99.0

(97.5;100.0)

SeC-ELISA

92.6

(84.5; 98.3)

90.4

(80.0; 99.5)

-

-

93.6

(82.5; 99.8)

SpC-ELISA

96.1

(92.8; 99.4)

97.0

(92.4; 100.0)

-

-

83.2

(72.9; 98.5)

SeI-ELISA

92.3

(84.9; 98.0)

90.5

(82.7; 99.1)

91.6

(80.6; 99.4)

-

-

SpI-ELISA

93.7

(90.2; 97.7)

94.9

(90.0; 99.6)

82.4

(72.0; 97.5)

-

-

pvina

38.2

(31.1; 45.9)

39.8

(31.1; 48.6)

28.3

(12.5; 44.5)

25.8

(11.3; 43.0)

pmbere

26.7

(17.4; 37.9)

29.5

(18.6; 41.2)

11.8

(2.1; 29.1)

14.7

(2.0; 36.6)

pdjerem

21.0

(13.6; 29.4)

22.6

(14.4; 32.0)

16.0

(6.7; 30.3)

12.9

(5.4; 23.6)

pbanyo

31.5

(23.1; 40.7)

32.7

(23.7; 42.6)

17.8

(3.4; 37.9)

13.9

(1.5; 35.6)

pfaro

36.6

(26.0; 48.0)

37.6

(26.7; 49.2)

28.1

(13.8; 27.8)

28.3

(12.9; 46.2)